Skip to main content
Ind-Swift Laboratories Ltd. logo

Ind-Swift Laboratories Ltd. — Investor Relations & Filings

Ticker · INDSWFTLAB ISIN · INE915B01019 LEI · 335800ZT8UFD9Y8ZMP56 BSE.NS Manufacturing
Open in API
Filings indexed 809 across all filing types
Latest filing 2025-08-25 Share Issue/Capital Cha…
Country IN India
Listing BSE.NS INDSWFTLAB

About Ind-Swift Laboratories Ltd.

https://www.indswiftlabs.com

Ind-Swift Laboratories Ltd. is a global manufacturer specializing in Active Pharmaceutical Ingredients (APIs) and Advanced Intermediates. The company focuses on research and development, process chemistry, and large-scale production across diverse therapeutic segments, including macrolide antibiotics, cardiovascular agents, antihistamines, antidiabetics, and antipsychotics. Operating multiple manufacturing facilities that adhere to international regulatory standards such as USFDA, EDQM, and PMDA, the organization provides high-quality chemical entities to the global market. Its core competencies lie in complex chemical synthesis and the development of cost-effective manufacturing processes for generic and specialty drug substances. The company maintains a strong emphasis on quality assurance and regulatory compliance to support its extensive portfolio of products distributed worldwide.

Recent filings

Filing Released Lang Actions
Allotment of Securities
Share Issue/Capital Change Classification · 95% confidence The document is a formal letter addressed to stock exchanges (BSE and NSE) disclosing the allotment of equity shares pursuant to a Scheme of Arrangement (amalgamation) between two companies. It references compliance with SEBI Listing Regulations and details the number of shares allotted, record date, and the process for listing these shares. There is no financial data, earnings information, or detailed report content. The document is an announcement of a capital change event (share allotment) related to a merger scheme. It is not a full report, audit, or earnings release. Therefore, the appropriate classification is a Share Issue/Capital Change announcement (SHA). The document length is under 5,000 characters and is a direct disclosure, not a report publication announcement or regulatory filing. Confidence is high due to clear references to share allotment and capital changes.
2025-08-25 English
Outcome of Board Meeting
Board/Management Information Classification · 95% confidence The document is a formal communication titled 'OUTCOME OF BOARD MEETING' dated 25th August 2025, addressed to stock exchanges (BSE and NSE) and referencing compliance with SEBI Listing Regulations. It details the decisions taken by the Board of Directors in their meeting, including re-appointment of cost auditors and secretarial auditors, and the scheduling of the 30th Annual General Meeting (AGM). The document includes annexures providing detailed information about the auditor appointments. The content is focused on announcements related to board decisions and compliance disclosures rather than a full financial report or earnings release. It does not contain financial statements or detailed financial analysis. Therefore, it fits best under the category of Board/Management Information (MANG), which covers announcements of changes or appointments in the company's board or senior management and related compliance disclosures.
2025-08-25 English
Monitoring Agency Report
Capital/Financing Update Classification · 95% confidence The document is titled 'Monitoring Agency Report for the quarter ended 30th June, 2025 for funds raised through preferential issue' and is issued pursuant to SEBI regulations related to preferential issues and capital raising. It contains detailed monitoring of the utilization of proceeds from a preferential issue, including certifications, bank statements, and management certificates. The report is prepared by a monitoring agency (CARE Ratings Limited) and is addressed to stock exchanges and the company's board. The content focuses on compliance with capital raising regulations and the use of funds, not on general financial results or earnings. It is not an earnings release, annual or interim report, or a proxy statement. It is a regulatory compliance report related to capital raising and monitoring of proceeds. This fits best under the category of Capital/Financing Update (CAP), as it provides updates on the use of funds raised through a preferential issue and compliance with related regulations.
2025-08-14 English
Outcome of Board Meeting
Regulatory Filings
2025-08-13 English
Outcome of Board Meeting
Regulatory Filings
2025-08-13 English
Outcome of Board Meeting
Regulatory Filings
2025-08-12 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.